Sirio Pharma Co Ltd
SZSE:300791
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sirio Pharma Co Ltd
PP&E Net
Sirio Pharma Co Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sirio Pharma Co Ltd
SZSE:300791
|
PP&E Net
¥2.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
PP&E Net
¥10.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
PP&E Net
¥1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
PP&E Net
¥3B
|
CAGR 3-Years
34%
|
CAGR 5-Years
25%
|
CAGR 10-Years
16%
|
|
|
S
|
Shanghai Chicmax Cosmetic Co Ltd
HKEX:2145
|
PP&E Net
¥1.4B
|
CAGR 3-Years
24%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
PP&E Net
¥1.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Sirio Pharma Co Ltd
Glance View
Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.
See Also
What is Sirio Pharma Co Ltd's PP&E Net?
PP&E Net
2.3B
CNY
Based on the financial report for Sep 30, 2025, Sirio Pharma Co Ltd's PP&E Net amounts to 2.3B CNY.
What is Sirio Pharma Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
27%
Over the last year, the PP&E Net growth was 18%. The average annual PP&E Net growth rates for Sirio Pharma Co Ltd have been 21% over the past three years , 27% over the past five years .
